Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 4 records, 1 pages
Search For: Beta-Nicotinamide Mononucleotide (NMN)
Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2024-2030
22 Apr 2024
Chemical & Material
Beta-Nicotinamide Mononucleotide (NMN)
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
USD4480.00
Add To Cart
Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
22 Apr 2024
Chemical & Material
Beta-Nicotinamide Mononucleotide (NMN)
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
USD3480.00
Add To Cart
Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2023-2029
29 Jun 2023
Chemical & Material
Beta-Nicotinamide Mononucleotide (NMN)
The global Beta-Nicotinamide Mononucleotide (NMN) market size is expected to reach $ 679.1 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Beta-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
29 Jun 2023
Chemical & Material
Beta-Nicotinamide Mononucleotide (NMN)
According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Beta-Nicotinamide Mononucleotide (NMN)
Total: 4 records, 1 pages
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
USD4480.00
Add To Cart
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
USD3480.00
Add To Cart
The global Beta-Nicotinamide Mononucleotide (NMN) market size is expected to reach $ 679.1 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>